Evidence map›Paper›PMID 35718229›Full record

ArticleBehavioural brain research2022

Mice expressing P301S mutant human tau have deficits in interval timing.

Travis Larson, Vaibhav Khandelwal, Matthew A Weber, Mariah R Leidinger, David K Meyerholz, Nandakumar S Narayanan, Qiang Zhang

Open access · greenAbstract read
In one paragraph

Article in Behavioural brain research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Glycolysis-enhancing αAlzheimer's research & therapy · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Glycolysis-enhancing αNPJ Parkinson's disease · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Travis LarsonMedical Scientist Training Program, Duke University School of Medicine, United States of America; Department of Neurology, University of Iowa, United States of America.
Vaibhav KhandelwalDepartment of Neurology, University of Iowa, United States of America.
Matthew A WeberDepartment of Neurology, University of Iowa, United States of America.
Mariah R LeidingerDepartment of Pathology, University of Iowa, United States of America.
David K MeyerholzDepartment of Pathology, University of Iowa, United States of America.
Nandakumar S NarayananDepartment of Neurology, University of Iowa, United States of America.
Qiang ZhangDepartment of Neurology, University of Iowa, United States of America.
University of Iowa · USDuke University · US

Funding

Timing and dopamine in frontostriatal circuitsR01MH116043 · NIMH · UNIVERSITY OF IOWA · PI NARAYANAN, NANDAKUMAR · 2018 to 2022
$2.4M
VTA dopamine neurons and cognitive symptoms of Parkinson’s diseaseR01NS120987 · NINDS · UNIVERSITY OF IOWA · PI NARAYANAN, NANDAKUMAR · 2021 to 2025
$2.0M
NIMH NIH HHS R01 MH116043NINDS NIH HHS R01 NS120987
6 · The paper itself

Abstract

Interval timing is a key executive process that involves estimating the duration of an interval over several seconds or minutes. Patients with Alzheimer's disease (AD) have deficits in interval timing. Since temporal control of action is highly conserved across mammalian species, studying interval timing tasks in animal AD models may be relevant to human disease. Amyloid plaques and tau neurofibrillary tangles are hallmark features of AD. While rodent models of amyloid pathology are known to have interval timing impairments, to our knowledge, interval timing has not been studied in models of tauopathy. Here, we evaluate interval timing performance of P301S transgenic mice, a widely studied model of tauopathy that overexpresses human tau with the P301S mutation. We employed an interval timing task and found that P301S mice consistently underestimated temporal intervals compared to wild-type controls, responding early in anticipation of the target interval. Our study indicating timing deficits in a mouse tauopathy model could have relevance to human tauopathies such as AD.

Indexed as

Alzheimer DiseaseTauopathiesAnimalsDisease Models, AnimalHumansMammalsMiceMice, Transgenictau Proteinstau ProteinsAlzheimer’s diseaseFrontotemporal dementiaInterval timingSwitch taskTauopathy

Identifiers

PMID35718229
PMCPMC9585768
OpenAlexW4283028679

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.